Dysfunction in TrkB signaling has been linked to various neurological disorders, including Alzheimer's disease, depression, and schizophrenia. For instance, reduced levels of BDNF and impaired TrkB signaling are often observed in patients with depression. Therapeutic strategies aiming to enhance TrkB signaling are being explored for the treatment of these conditions.
